https://t.co/eXEjmJq6U9 Delighted with this recognition for the #ShorlaPharma team! Thanks @IrishTimes @IrishTimesBiz @KPMG @EirGrid

.@ShorlaOncology Announces FDA Approval of IMKELDI (imatinib) Oral Solution, an Oral Liquid for the Treatment of Certain Forms of Leukemia and Other Cancers

Join us in raising awareness for breast cancer and supporting those affected by this disease. Early detection saves lives—make sure to schedule your screenings and encourage your loved ones to do the same. #BreastCancerAwareness

A momentous day for us at Shorla Oncology as we announce U.S. FDA approval of our oncology drug. TEPYLUTE, an injectible drug, is a ready-to-dilute, novel formulation that enables accurate dosing to treat breast and ovarian cancer #Oncology

Great panel with @eDougBanks, @sharcunningham, @daphnezohar, and @mike_nally at @MassBio’s #StateofPossible24 Conference. We discussed the need for resilience in biopharma, the importance of aligning policy & innovation, & how to collectively work towards equitable patient care.

Our team are looking forward to attending Asembia in Las Vegas April 28 – May 2 #ASEMBIA24

Our team are delighted to be attending the @HOPArx 2024 conference in Tampa Florida from 3-6 April. We're looking forward to meeting you at Booth #620! #HOPA2024

As we live our company values in the pursuit of our mission together, I’m continuously inspired by our innovative and tenacious team whose steadfast commitment to achieving our goals collaboratively and compassionately keeps the momentum going!

.@ShorlaOncology Shorla Announces FDA Filing Acceptance of New Drug Application for Novel Formulation to Treat Breast and Ovarian Cancer https://t.co/Zt3cmdPepc

I'm delighted to jump on board the event committee with @Irishaporg & we're looking forward to a lovely morning celebrating women's leadership in Boston this Friday - proceeds for causes in education & the arts in Ireland. Join us! https://t.co/seY9Rp2kf9 @donie

.@ShorlaOncology & @EVERSANAcompany Announce U.S. Commercial Launch of FDA-Approved JYLAMVO, the First and Only Oral Methotrexate Solution Approved in the U.S. for Adults https://t.co/79Uoe689KA

.@sharcunningham, Orlaith Ryan and Rayna Herman are looking forward to meeting Key Opinion Leaders at the American Society of Hematology's annual meeting in San Diego this week #ASH23

.@ShorlaOncology welcomes Rayna Sethi Herman as Chief Commercial Officer - Industry veteran brings more than three decades of leadership and experience in life sciences commercialization to lead Shorla’s continued US expansion

The company chosen for this year’s Business Award of the Year epitomises the very best of innovation, inspiration, leadership and entrepreneurship. Introducing the winners of the #WOTYA23 Business Award sponsored by @Entirl is @ShorlaOncology #WOTYA23

Irish pharmaceutical company brings cancer drug to US for patients with 'difficulty swallowing pills' https://t.co/9bQyGliX1J

.@ShorlaOncology announce US acquisition of Jylamvo, an Oncology and Autoimmune Drug, with commercialization to begin immediately https://t.co/qvegkVdmcg

Well done to @ShorlaOncology the Irish speciality pharma company led by @sharcunningham. It has raised $35m to further devleop its portfolio of oncology drugs

Today is a big day for us at @ShorlaOncology as we announce the completion of our $35m Series B round to continue to advance & commercialize our oncology drugs. Very proud of how far we have come in the almost 6 years since beginning this journey – a lot done, plenty more to do!

Honoured to join a panel discussion on Opportunity, Prosperity, and Investing in the Future on Tuesday at the Edward M. Kennedy Institute for the U.S. Senate & to hear from Senator George Mitchell, Rep. Richard Neal & Joe Kennedy III @RepRichardNeal @USEnvoyNI @EMKInstitute

Great to host Friends of Ireland dinner with ⁦@NIBRT_⁩ and ⁦@IDAIRELAND⁩ and to be joined by many colleagues including ⁦@ShorlaOncology⁩

Drop in to the student hub and meet employers from @ShorlaOncology @Cadence @mbryonics @Pharmabiotic ✨